Gujarat, India

Sunil Sadanand Nadkarni

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 3.7

ph-index = 8

Forward Citations = 423(Granted Patents)


Location History:

  • Bhat, IN (2013 - 2016)
  • Gandhinagar, IN (2015 - 2017)
  • Gujarat, IN (2003 - 2022)

Company Filing History:


Years Active: 2003-2022

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Sunil Sadanand Nadkarni: Innovator in Pharmaceutical Composition

Introduction

Sunil Sadanand Nadkarni is a prominent inventor based in Gujarat, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for pain management. With a total of 14 patents to his name, Nadkarni's work has had a substantial impact on medical treatments.

Latest Patents

Among his latest innovations, Nadkarni has developed a pharmaceutical composition of tapentadol for nasal administration. This invention relates to a method of preparing a pharmaceutical composition that is effective in treating pain through nasal delivery. Additionally, he has created a pharmaceutical composition of tapentadol for parenteral administration, which offers prolonged release of the medication, enhancing its effectiveness in pain management.

Career Highlights

Throughout his career, Nadkarni has worked with notable companies such as Torrent Pharmaceuticals Limited and J.M. Huber Corporation. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in pharmaceutical technology.

Collaborations

Nadkarni has collaborated with professionals like Navin Vaya and Rajesh Singh Karan, further enriching his work and expanding the scope of his inventions.

Conclusion

Sunil Sadanand Nadkarni's contributions to pharmaceutical compositions demonstrate his commitment to innovation in pain management. His patents reflect a deep understanding of medical needs and a dedication to improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…